Letter from Rick Doblin, MAPS President

MDMA Neurotoxicity Research: Methodological Concerns
Charles Grob, MD

MDMA Neurotoxicity Discussed
Rick Doblin

MDMA and Memory Impairment: Proven or Not Proven?
K. Thomas Nelson, Ph.D.

Reviewing the Latest Research with MDMA and MDE: Introduction to a recent MAPS-organized conference

Proposal for a Study with MDMA and Post Traumatic Stress Disorder in Spain
Jose Carlos Bouso Saiz

MDMA in a Couple Struggling with Cancer: Two Years Later
Sue

Cannabis in Migraine Treatment Project Moves Closer to FDA Approval
Ethan Russo, MD

MAPS Succeeds in Securing an Orphan Drug Designation for Marijuana
Rick Doblin

Medical Cannabis Potency Testing
Dale Gieringer, Ph.D.

Do Entheogen-Induced Mystical Experiences Boost the Immune System?
Thomas B. Roberts, Ph.D.

Interested parties wishing to copy any portion of this publication are encouraged to do so and are kindly requested to credit MAPS including name and address. The MAPS Bulletin is produced by a small group of dedicated staff and volunteers. Your participation, financial or otherwise, is welcome.
©1999 MAPS - Multidisciplinary Association for Psychedelic Studies, Inc. (MAPS)